Systemic impairment in relation to disease burden in patients with moderate COPD eligible for a lifestyle program. Findings from the INTERCOM trial

International Journal of COPD

Volumn 3, Issue 3, 2008, Pages 443-451

  van Wetering, Carel R ^a   van Nooten, Floortje E ^b   Mol, Stijn J M ^a   Hoogendoorn, Martine ^b   Rutten van Mölken, Maureen P M H ^b   Schols, Annemie M ^c  

^a MÁXIMA MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

COPD; Lifestyle; Pulmonary rehabilitation; Systemic impairment

Indexed keywords

AGED; AIRWAY OBSTRUCTION; ARTICLE; BICYCLE ERGOMETER; BODY COMPOSITION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DYNAMOMETER; DYSPNEA; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HUMAN; LIFESTYLE MODIFICATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MUSCLE FORCE; MUSCLE STRENGTH; PREDICTION; PULMONARY REHABILITATION; QUADRICEPS FEMORIS MUSCLE; QUALITY OF LIFE; QUESTIONNAIRE; REFERENCE VALUE; SMOKING HABIT; SYSTEMIC DISEASE;

AGED; BODY COMPOSITION; BODY MASS INDEX; COST OF ILLNESS; COST-BENEFIT ANALYSIS; EXERCISE TOLERANCE; FEMALE; HEALTH BEHAVIOR; HOSPITALIZATION; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING CESSATION;

EID: 54949129103     PISSN: 11769106     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Baarends EM, Schols AM, Mostert R, et al. 1997. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J, 10:1856-61.
2. Bestall JC, Paul EA, Garrod R, et al. 1999. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax, 54:581-6.
3. Black LF, Hyatt RE. 1969. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis, 99:696-702.
4. Bourbeau J, Julien M, Maltais F, et al. 2003. Reduction in hospital utilization in patients with chronic obstructive pulmonary disease. Arch Intern Med, 163:585-91.
5. Broekhuizen R, Wouters E, Creutzberg E, et al. 2006. Elevated CRP levels mark metabolic and functional impairment in advanced COPD. Thorax, 61:17-22.
6. Clark CJ. Cochrane LM, Mackay E, et al. 2000. Skeletal muscle strength and endurance in patients with mild COPD and the effects of weight. Eur Respir J, 15:92-7. Erratum, Eur Respir J, 2000; 15:816.
7. Corronell C, Orozco-Levi M, Méndez R, et al. 2004. Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J, 24:129-36.
8. Creutzberg E, Postma S, Hop J, et al. 2004. Systemic inflammatory response during one year follow-up in patients with COPD. Eur Respir J, 24:(Suppl 48)13s.
9. Decramer M, Gosselink R, Troosters T, et al. 1997. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J, 10:417-23.
10. Engelen MP, Schols AM, Does JD, et al. 2000. Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease. Am J Clin Nutr, 71:733-8.
11. Fletcher CM, Elmes PC, Wood CH. 1959. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J, 1:257-66.
12. Gosselink R, Troosters T, Decramer M. 1996. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med, 153:976-80.
13. Gray-Donald K, Gibbons L, Shapiro SH, et al. 1996. Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 153:961-6.
14. Griffiths TL, Phillips CJ, Davies S, et al. 2001. Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax, 56:779-84.
15. Hamilton AL, Killian KJ, Summers E, et al. 1995. Muscle strength, symptom intensity and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med, 152:2021-31.
16. Hoogendoorn M, Feenstra TL, Schermer TR, et al. 2006. Severity distribution of chronic obstructive pulmonary disease (COPD) in Dutch general practice. Respir Med, 100:83-6.
17. Hurd S. 2000. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest, 117:1S-4S.
18. Jones NL, Makrides L, Hitchcock C, et al. 1985. Normal standards for an incremental progressive cycle ergometer test. Am Rev Respir Dis, 131:700-8.
19. Jones PW, Quirk FH, Baveystock CM, et al. 1992. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis, 145:1321-7.
20. Landbo C, Prescott E, Lange P, et al. 1999. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 160:1856-61.
21. Landis J, Koch G. 1977. The measurement of observer agreement for categorical data. Biometrics, 33:159-74.
22. Murray CJL, Lopez AD. 1997. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet, 349:1269-76.
23. Nici L, Donner C, Wouters E, et al. 2006. American Thoracic Society/ European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med, 173:1390-413.
24. Palange P, Forte S, Felli A, et al. 1995. Nutritional state and exercise tolerance in patients with COPD. Chest, 107:1206-12.
25. Pinto-Plata VM, Mullerova H, Toso JF, et al. 2006. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax, 61:23-8.
26. Quanjer PH. 1993. Standardized lung function testing. Official statement of the European Respiratory Society. Eur Respir J, 6(suppl 16):1-100.
27. Schols AM, Broekhuizen R, Weling-Scheepers CA, et al. 2005. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr, 82:53-9.
28. Schols AMWJ, Wouters EFM, Soeters PB, et al. 1991. Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr, 53:421-4.
29. Steuten LM, Creutzberg EC, Vrijhoef HJ, et al. 2006. COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim Care Respir J, 15:84-91.
30. Torres JP, Cordoba-Lanus E, López-Aguilar C, et al. 2006. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. Eur Respir J, 27:902-7.
31. Wouters EF. 2002. Chronic obstructive pulmonary disease: systemic effects of COPD. Thorax, 57:1067-70.